Efficacy, safety and patient's satisfaction for treatment of genital psoriasis with tildrakizumab: a case series and review of literature

J Eur Acad Dermatol Venereol. 2022 Nov;36(11):e916-e918. doi: 10.1111/jdv.18368. Epub 2022 Jul 4.
No abstract available

Publication types

  • Letter
  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antibodies, Monoclonal, Humanized / adverse effects
  • Genitalia
  • Humans
  • Patient Satisfaction*
  • Psoriasis* / complications
  • Psoriasis* / drug therapy
  • Treatment Outcome

Substances

  • Antibodies, Monoclonal, Humanized
  • tildrakizumab